INTRODUCTION & OBJECTIVES Vitiligo is a common disease with an immunological background. There is no standard treatment regimen for vitiligo. Interleukin 17 (IL-17) may play a role in pathogenesis of vitiligo. Evaluation of Tacrolimus and Narrow band UVB (NB-UVB) in treatment of vitiligo both clinically and by measurement of IL-17 before and after treatment. MATERIALS & METHODS 45 patients with ... Read more

Background Etiopathogenesis of vitiligo is unclear. Immunological background has a role.Interleukin 17 (IL-17) may play a role in its pathogenesis. There is no standard treatment regimen for vitiligo; however, calcineurin inhibitors may be an effective treatment option. Objective The aim was to evaluate tacrolimus versus narrowband ultraviolet B (NB-UVB) intreatment of vitiligo, both clinically and by measurement of IL-17 before ... Read more